Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT01109498
Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Phase: Phase 2/3
Role: Lead Sponsor
Start: Aug 31, 2007
Completion: Jun 30, 2013
NCT00891306
Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Start: Feb 28, 2009
Completion: Apr 30, 2011
NCT01448577
"Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal Pancreatitis Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies"
Phase: N/A
Start: Nov 30, 2010
Completion: Mar 31, 2016
NCT01447901
Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Start: Sep 30, 2011
Completion: Sep 30, 2012